Log in to save to my catalogue

Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunot...

Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunot...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3e7b6b54104143d6819770a8ea596373

Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium

About this item

Full title

Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium

Publisher

London: Nature Publishing Group UK

Journal title

Blood cancer journal (New York), 2024-04, Vol.14 (1), p.63-5, Article 63

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_3e7b6b54104143d6819770a8ea596373

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3e7b6b54104143d6819770a8ea596373

Other Identifiers

ISSN

2044-5385

E-ISSN

2044-5385

DOI

10.1038/s41408-024-00993-0

How to access this item